A short bilingual clip where the two hosts cover what the GLP-1 hormone is and how treatments like Mounjaro build on it.
Recap by typeshit. Post by Facebook on Facebook.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
Lilly Medical points to newly published results from a double-blind, placebo-controlled phase 3 study of its triple-hormone shot in people with diabetes.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
Becker's cites FDA and Eli Lilly reports on the deaths, which add to concerns over illicit versions of the unapproved weight loss drug.
A new 'In Discussion With' episode features Sehar Shahid on what makes losing weight difficult. Little else is shared beyond the topic.
Loading…